01 April 2021
The World Health Organization (WHO) has warned that a falsified COVID-19 vaccine, identified as Pfizer’s BNT162b2, could still be in circulation in the Americas.
The World Health Organization (WHO) has issued a Medical Product Alert (N°2/2021) because its Global Surveillance and Monitoring System for Substandard and Falsified Medical Products has detected falsified COVID-19 vaccines in Mexico.
The counterfeit vaccines, labelled as ‘BNT162b2’ (the name of Pfizer-BioNTech’s Comirnaty® while it was under development), were identified in February 2021 and recently confirmed as falsified to the WHO. The product was supplied and administered to patients outside of authorised vaccination programmes.
According to WHO’s alert, this falsified COVID-19 vaccine may still be in circulation in the Americas and continue to be offered to patients outside authorised vaccination programs. This, and other falsified vaccines, pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems.
The product was confirmed as falsified by three means:
Laboratory analysis of the contents of the falsified products is pending and WHO stated that its alert would be updated as soon as results are available.
In response to the alert, WHO has requested that supply chain players in countries and regions particularly vulnerable to falsified products be more vigilant. Such players include those in hospitals, clinics, health centres, wholesalers, distributors, pharmacies and any other suppliers of medical products.
Below Table 1 contains the information WHO provided about the falsified product and Figure 1 shows photographs of it.
Table 1: Products subject of WHO Medical Product Alert N°2/2021 [Credit: WHO].
Figure 1: Photographs of products subject of WHO Medical Product Alert N°2/2021 [Credit: WHO].
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024